These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13524526)

  • 1. [Acquisition of toxohormone-like activity by serum constituents following certain chemical treatment].
    ONO T; UMEDA M; SUGIMURA T; FUCHIGAMI A
    Gan; 1957 Dec; 48(4):601-2. PubMed ID: 13524526
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical nature of toxohormone (Nakahara). VI. The group mucopolysaccharide from pig stomach mucus acts as a weak toxohormone.
    MASAMUNE H; SINOHARA H; ABE S; KAKETA H
    Tohoku J Exp Med; 1958 Dec; 69(1):53-7. PubMed ID: 13659520
    [No Abstract]   [Full Text] [Related]  

  • 3. Biosynthesis of toxohormone; a seventh study on toxohormone, the characteristic toxic substance produced by cancer tissue.
    NAKAHARA W; FUKUOKA F
    Gan; 1954 Mar; 45(1):77-85. PubMed ID: 13183270
    [No Abstract]   [Full Text] [Related]  

  • 4. Dialyzable form of toxohormone: a sixth study on toxohormone, a characteristic toxic substance produced by cancer tissue.
    NAKAHARA W; FUKUOKA F
    Gan; 1954 Mar; 45(1):67-75. PubMed ID: 13183269
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fractionation of toxohormone-like principle in urine extracts of patients with carcinoma--comparative studies of the biological activities of carcinoma urine extract, toxohormone and of bacterial lipopolysaccharide].
    Akigawa K
    Sapporo Igaku Zasshi; 1967; 32(2):160-73. PubMed ID: 4873062
    [No Abstract]   [Full Text] [Related]  

  • 6. Amino acids and toxohormone synthesis; a fifth study on toxohormone, a characteristic toxic substance produced by cancer tissue.
    FUKUOKA F; NAKAHARA W
    Gan; 1953 Mar; 44(1):1-12. PubMed ID: 13107891
    [No Abstract]   [Full Text] [Related]  

  • 7. Purification and characterization of a lipolytic factor (toxohormone-L) from cell-free fluid of ascites sarcoma 180.
    Masuno H; Yamasaki N; Okuda H
    Cancer Res; 1981 Jan; 41(1):284-8. PubMed ID: 7448767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of toxohormone. A second study of toxohormone, a characteristic toxic substance produced by cancer tissues.
    NAKAHAKA W; FUKUOKA F
    Gan; 1950 Mar; 41(1):47-56. PubMed ID: 15414900
    [No Abstract]   [Full Text] [Related]  

  • 9. Mode of action of toxohormone; a third study on toxohormone, a characteristic toxic substance produced by cancer tissue.
    FUKUOKA F; NAKAHARA W
    Gan; 1951 Mar; 42(1):55-68. PubMed ID: 14823180
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical nature of toxohormone (Nakahara). II. The KIK factor (V) from cancerous urine and the corresponding component of normal urine act as toxohormones.
    MASAMUNE H; KAKETA H; ABE S
    Tohoku J Exp Med; 1958 Apr; 67(4):329-33. PubMed ID: 13581049
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholinesterase activity of blood serum in neoplasms].
    RAGAZZONI L; LODI A
    Friuli Med; 1953; 8(4):404-12. PubMed ID: 13107856
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical nature of toxohormone (Nakahara). 3. KIK-in-active toxohormones from urines, cancerous and normal.
    MASAMUNE H; HAKOMORI S; KAKETA H; SINOHARA H; ABE S
    Tohoku J Exp Med; 1958 Jun; 68(1):63-73. PubMed ID: 13592847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the mechanism of toxohormone activity].
    MIZUHARA S
    Gan; 1957 Dec; 48(4):600-1. PubMed ID: 13524525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proton NMR-relaxation of nonaqueous components of human blood serum].
    Gangardt MG; Kariakina NF; Pavlov AS; Papish EA
    Biull Eksp Biol Med; 1995 Oct; 120(10):445-8. PubMed ID: 8595245
    [No Abstract]   [Full Text] [Related]  

  • 15. On the fractionation of toxohormone-like principle in cancerous urine extract.
    Okada K
    Sapporo Igaku Zasshi; 1965 Sep; 28(3):234-52. PubMed ID: 5895805
    [No Abstract]   [Full Text] [Related]  

  • 16. [Certain properties of blood proteins in malignant neoplasms].
    ZOKHRABBEKOV ZS
    Tr Akad Med Nauk Sssr Mosc Inst Grudn Khir; 1952; 21():93-7. PubMed ID: 14359439
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of blood serum of patients with malignant neoplasms and of healthy individuals on phagocytic leukocyte activity].
    Mardakhiashvili ShI
    Patol Fiziol Eksp Ter; 1965; 9(6):71-2. PubMed ID: 5873929
    [No Abstract]   [Full Text] [Related]  

  • 18. [Slowing of catalase activity in presence of cancerous serum].
    CERVIGNI T
    Biol Lat; 1954; 7(4):929-34. PubMed ID: 13230156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of determination method for trace cobalt in serum of cancer patients].
    Cheng T; Sun X; Zhang S
    Guang Pu Xue Yu Guang Pu Fen Xi; 1998 Dec; 18(6):715-8. PubMed ID: 15825287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human serum steroid-binding proteins and malignancy (review).
    Englebienne P
    Anticancer Res; 1989; 9(6):1769-76. PubMed ID: 2697187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.